Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Revenue (2016 - 2026)

Ekso Bionics Holdings has reported Revenue over the past 13 years, most recently at $3.1 million for Q4 2025.

  • On a quarterly basis, Revenue fell 38.31% to $3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.8 million, a 28.6% decrease, with the full-year FY2025 number at $12.8 million, down 28.6% from a year prior.
  • Revenue reached $3.1 million in Q4 2025 per EKSO's latest filing, down from $4.2 million in the prior quarter.
  • The five-year high for Revenue was $5.1 million in Q4 2024, with the low at $1.9 million in Q1 2021.
  • The 5-year median for Revenue is $3.7 million (2022), against an average of $3.7 million.
  • Peak YoY movement for Revenue: surged 60.58% in 2023, then crashed 58.44% in 2025.
  • Tracing EKSO's Revenue over 5 years: stood at $4.1 million in 2021, then dropped by 12.88% to $3.6 million in 2022, then surged by 36.5% to $4.8 million in 2023, then grew by 5.01% to $5.1 million in 2024, then tumbled by 38.31% to $3.1 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $3.1 million, $4.2 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.